AGM
GOSS icon

Alpine Global Management’s Gossamer Bio GOSS Stock Holding History

Alpine Global Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6
Closed -$500 – 376
2025
Q3 		$500 Buy
+6
New +$1.06K ﹤0.01% 229

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DeepCurrents Investment Group
DeepCurrents Investment Group New York $3.49B AUM 0.78% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Worth Venture Partners
Worth Venture Partners Fort Lee, New Jersey $38.9M AUM 12.3% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GSA Capital Partners
GSA Capital Partners London, United Kingdom $1.59B AUM 39.8% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $132M AUM 92.09% 1-Year Est. Return

Alpine Global Management's GOSS Position: Q2 2026 in Review

Alpine Global Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 410 shares — an estimated $10.8K sold.

Alpine Global Management first reported a position in GOSS in Q4 2019 and held it in 2 quarters. The position peaked at $261K in Q4 2019. 167 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Alpine Global Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Alpine Global Management sold 410 Gossamer Bio shares in Q2 2026, an estimated $10.8K.
  • Alpine Global Management first reported a position in Gossamer Bio in Q4 2019 and held it in 2 quarters.
  • Alpine Global Management's Gossamer Bio position peaked at $261K in Q4 2019.
  • 167 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Alpine Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.